| IL4 |
P05112
|
interleukin 4
|
|
4.7E-03 |
0.332 |
0.962 |
| BDNF |
P23560
|
brain derived neurotrophic factor
|
Signaling
|
0.66 |
0.345 |
0.923 |
| MTHFR |
P42898
|
methylenetetrahydrofolate reductase
|
|
3.2E-10 |
0.337 |
0.885 |
| MTOR |
P42345
|
mechanistic target of rapamycin kinase
|
Kinase
|
1.00 |
0.343 |
0.885 |
| IL2 |
P60568
|
interleukin 2
|
|
0.48 |
0.336 |
0.885 |
| ABCB1 |
P08183
|
ATP binding cassette subfamily B member 1
|
Transporter
|
1.3E-05 |
0.344 |
0.885 |
| CCND1 |
P24385
|
cyclin D1
|
Enzyme modulator
|
0.89 |
0.344 |
0.923 |
| AR |
P10275
|
androgen receptor
|
Nuclear receptor
|
0.99 |
0.351 |
0.846 |
| SPP1 |
P10451
|
secreted phosphoprotein 1
|
|
2.1E-06 |
0.353 |
0.885 |
| MYC |
P01106
|
MYC proto-oncogene, bHLH transcription factor
|
Transcription factor
|
1.00 |
0.344 |
0.923 |
| CASP3 |
P42574
|
caspase 3
|
Enzyme
|
0.10 |
0.351 |
0.923 |
| FGFR1 |
P11362
|
fibroblast growth factor receptor 1
|
Kinase
|
1.00 |
0.362 |
0.885 |
| TP63 |
Q9H3D4
|
tumor protein p63
|
Transcription factor
|
1.00 |
0.362 |
0.769 |
| NOS2 |
P35228
|
nitric oxide synthase 2
|
|
4.0E-15 |
0.364 |
0.923 |
| H3P10 |
|
H3 histone pseudogene 10
|
|
|
0.350 |
0.846 |
| FAS |
P25445
|
Fas cell surface death receptor
|
|
0.81 |
0.372 |
0.923 |
| IL18 |
Q14116
|
interleukin 18
|
|
3.1E-02 |
0.365 |
0.923 |
| CXCR4 |
P61073
|
C-X-C motif chemokine receptor 4
|
G-protein coupled receptor
|
1.8E-02 |
0.362 |
0.923 |
| MIR21 |
|
microRNA 21
|
|
|
0.363 |
0.846 |
| CTLA4 |
P16410
|
cytotoxic T-lymphocyte associated protein 4
|
|
0.94 |
0.369 |
0.923 |
| KIT |
P10721
|
KIT proto-oncogene, receptor tyrosine kinase
|
Kinase
|
0.98 |
0.366 |
0.808 |
| CD44 |
P16070
|
CD44 molecule (Indian blood group)
|
|
2.4E-07 |
0.363 |
0.962 |
| APC |
P25054
|
APC regulator of WNT signaling pathway
|
|
1.00 |
0.373 |
0.962 |
| TERT |
O14746
|
telomerase reverse transcriptase
|
Enzyme
|
0.99 |
0.374 |
0.846 |
| PTPN11 |
Q06124
|
protein tyrosine phosphatase non-receptor type 11
|
|
1.00 |
0.385 |
0.923 |